Back
Arvinas Vs. Kymera Therapeutics Industry Stock Comparison
Sell
39
ARVN
Arvinas
Last Price:
24.78
Seasonality Move:
3.51%
Buy
54
KYMR
Kymera Therapeutics
Last Price:
45.72
Seasonality Move:
25.63%
Sell
39
Arvinas (ARVN)
is a Sell
Is Arvinas a Buy, Sell or Hold?
- The current Arvinas [ARVN] share price is $24.90. The Score for ARVN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ARVN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $44.77. The Score for KYMR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ARVN Stock Price Chart
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $44.77
The current trend is moderately bearish and KYMR is experiencing selling pressure, which indicates risk of future bearish movement.
ARVN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.33 | Sell |
| Relative Strength Index (14 RSI): | 45.27 | Sell |
| Chaikin Money Flow: | -75431 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.49 - 25.87) | Sell |
| Bollinger Bands (100): | (24.9 - 31.92) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.88 | Buy |
| Relative Strength Index (14 RSI): | 48.13 | Sell |
| Chaikin Money Flow: | -245093 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.03 - 48.09) | Sell |
| Bollinger Bands (100): | (32.8 - 44.58) | Buy |
ARVN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.2 | Sell |
| 20-day SMA: | 25.33 | Sell |
| 50-day SMA: | 26.45 | Sell |
| 200-day SMA: | 34.16 | Sell |
| 8-day EMA: | 25.19 | Sell |
| 20-day EMA: | 25.44 | Sell |
| 50-day EMA: | 26.49 | Sell |
| 200-day EMA: | 30.42 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.33 | Sell |
| 20-day SMA: | 46.49 | Sell |
| 50-day SMA: | 43.27 | Buy |
| 200-day SMA: | 35.7 | Buy |
| 8-day EMA: | 46.22 | Sell |
| 20-day EMA: | 45.92 | Sell |
| 50-day EMA: | 43.32 | Buy |
| 200-day EMA: | 36.21 | Buy |
Arvinas Earnings Growth & ARVN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.65 per share, an increase this year of $1.66 per share, and a decrease next year of $1.40 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.51 per share.
Arvinas Technical Analysis
| Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||